The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Adare Pharmaceuticals Announces Changes to Executive Leadership Team; Supports Next Phase of Growth
Finance

Adare Pharmaceuticals Announces Changes to Executive Leadership Team; Supports Next Phase of Growth

MAY 9, 2018
UAS Laboratories Expands Capabilities With New Fermentation Facility
Finance

UAS Laboratories Expands Capabilities With New Fermentation Facility

MAY 6, 2018
Jennewein Biotechnologie: First Clinical Trial of a Blend of Human Milk Oligosaccharides Emulating the Human Profile of Infant Formula
Clinical & Manufacturing

Jennewein Biotechnologie: First Clinical Trial of a Blend of Human Milk Oligosaccharides Emulating the Human Profile of Infant Formula

MAY 6, 2018
CosmosID Microbiome Technology Wins Prestigious Global Water Summit Technology Idol Award
Phytobiome & Environment

CosmosID Microbiome Technology Wins Prestigious Global Water Summit Technology Idol Award

MAY 3, 2018
Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Partners and Connecticut Innovations
Finance

Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Partners and Connecticut Innovations

MAY 2, 2018
Eagle Genomics Announces Senior Leadership Changes
Finance

Eagle Genomics Announces Senior Leadership Changes

MAY 2, 2018
Belgian Microbiome Start-up A-Mansia Announces €13m First Close of Series A Financing
Finance

Belgian Microbiome Start-up A-Mansia Announces €13m First Close of Series A Financing

APR 28, 2018
Dutch Biotech Micreos ‘Alternative to Antibiotics’ Wins Ideas From Europe Finals
Infectious Disease & AMR

Dutch Biotech Micreos ‘Alternative to Antibiotics’ Wins Ideas From Europe Finals

APR 26, 2018
The Global Prebiotic Association Welcomes Founding, Board and Associate Members
Pharma & Human Health

The Global Prebiotic Association Welcomes Founding, Board and Associate Members

APR 26, 2018
New initiative in the fight against antibiotic resistance
Infectious Disease & AMR

New initiative in the fight against antibiotic resistance

APR 26, 2018
BioGaia AB – Interim management statement 1 January – 31 March 2018
Finance

BioGaia AB – Interim management statement 1 January – 31 March 2018

APR 25, 2018